EGFR and hereditary clear cell renal cell carcinoma: This is not an in vitro-only phenomenon; renal cell carcinomas growing in FLCN KO mouse kidneys display strong activation of the EGFR signalling pathway and treatment of FTC-133 FLCN−/− mouse xenografts with the EGFR inhibitor Afatinib slowed tumour growth.